
|Articles|April 1, 2018
- Pharmaceutical Executive-04-01-2018
- Volume 38
- Issue 4
Pharmaceutical Executive, April 2018 Issue (PDF)
Click the title above to open the Pharmaceutical Executive April 2018 issue in an interactive PDF format.
Advertisement
Articles in this issue
almost 8 years ago
Rewriting Pharma’s Talent Blueprintalmost 8 years ago
Trading Big Pharma for Small Startupalmost 8 years ago
HEOR Education: Evolving the Skill Setalmost 8 years ago
Drug Marketing and Advertising Under Firealmost 8 years ago
A Watchful Eye on AIalmost 8 years ago
The New Talent Trajectoryalmost 8 years ago
HBA's Woman of the Year 2018almost 8 years ago
The New (Augmented) Reality in the Life Sciencesalmost 8 years ago
Med Affairs Building Up its Strategic Musclealmost 8 years ago
The Top Barriers to Patient PersistenceNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
From Evidence to Access: How Real-World Data Delivers for Patients
2
WHO Finalizes United States’ Withdrawal from Organization: Report
3
Pharma Companies Raise List Prices, Including 16 That Had Agreements to Lower Prices with Trump Administration: Report
4
Tariff Uncertainty Drives Short-Term Manufacturing Surge as Global Pharmaceuticals Enter Fragmented Growth Phase: Report
5



